News Center
LIZHU has been awarded the highest global MSCI ESG rating of AAA.
Release time:
2023-08-01
Recently, the international authoritative index company MSCI (Morgan Stanley Capital International) announced the latest annual ESG (Environmental, Social and Governance) rating results for Lijun. Lijun's MSCI ESG rating was upgraded from AA to the highest global rating of AAA, making it the first company in China's pharmaceutical industry to receive the highest MSCI ESG rating of AAA.
As of the date of this rating update, only 4 companies in the global pharmaceutical industry (a total of 76 companies evaluated) have received the highest MSCI ESG rating of AAA. In addition to Lijun, the other 3 companies are Merck from Germany, Novo Nordisk from Denmark, and Stryker from the United States. In addition, Lijun was awarded the 2023 Wind ESG rating of AA in May this year, currently ranking first among domestic pharmaceutical peers.
The level of ESG management is an important reference standard for global investors to measure the sustainability and social responsibility of listed companies. The performance of ESG ratings is an intuitive reflection of a company's ESG management level. Lijun has continuously published ESG reports for 7 years. We closely follow national policy trends, always adhere to the mission of "putting patient quality of life first," and embrace the vision of "becoming a leader in the pharmaceutical industry." We regard promoting inclusive health and public health as an important mission of our business operations, continuously focus on unmet clinical needs, steadily advance product innovation, enhance product accessibility and affordability, and ensure that our high-quality products benefit more people globally. We practice the concept of green and low-carbon operations, actively carry out energy conservation and emission reduction, increase the proportion of clean energy use, continuously optimize energy efficiency, and steadily move towards the goal of carbon neutrality by 2055. We always adhere to a people-oriented approach, providing every employee with the opportunity to grow and create value in an equal, respectful, inclusive, and diverse work environment. We actively undertake social responsibility and engage in public welfare activities such as chronic disease prevention and control, rural revitalization, and industrial assistance.
Those who act will succeed, and those who walk will reach their destination. In terms of ESG management and sustainable development capabilities, Lijun's leading position in the industry and awareness of social responsibility have been widely recognized and affirmed. In addition to the continuous and rapid improvement of MSCI ESG and Wind ESG ratings, the S&P Global Corporate Sustainability Assessment (S&P CSA) score also exceeds 90% of its global peers (as of November 2022), and has received numerous honors such as "Best ESG Practice Award," "Best ESG Practice Listed Company," and "Most Socially Responsible Listed Company." This is a true reflection of Lijun Group's deep integration of ESG concepts with high-quality sustainable development strategies and demonstrates Lijun Group's persistent pursuit of corporate social responsibility.
About MSCI ESG
MSCI is an international company that provides global indices and related derivative financial products. The MSCI index is the most widely used benchmark index by global portfolio managers, and its ESG rating results are an important basis for decision-making by major global investment institutions. Currently, the MSCI ESG rating covers 8,500 companies and over 680,000 global stocks and fixed-income securities (as of October 2020), mainly referencing companies' ESG reports, official websites, news reports, and other public information to assess the company's sustainable development performance from an ESG perspective, evaluate the ESG risks faced by enterprises, potential opportunities in core businesses, and ESG issues of general concern in the industry.
Previous Page
Related Information